Skip to content

Regatta Lateral System 36-181455-15Recalls & reported problems

Seaspine Orthopedics Corporation · Lateral Implant, 18mm x 14mm x 55mm, 15 Deg · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10889981158552), received between Oct 5, 2022 and Oct 5, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Migration or Expulsion of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Migration or Expulsion of Device1

Patient problems

  • Failure of Implant1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 5, 2022Migration or Expulsion of Device; Migration or Expulsion of Device

    ON (B)(6) 2022 A PATIENT UNDERWENT SPINAL SURGERY UTILIZING SEASPINE'S REGATTA INTERBODY AND PLATE SYSTEMS. ON 15 SEP 2022, SEASPINE WAS MADE AWARE THAT THE INTERBODY MIGRATED THREE WEEKS POST-OPERATIVELY. THE REPORTED FAILURE WAS CONFIRMED VIA PROVIDED X-RAY.

    Patient problems: Failure of Implant

    MAUDE report 15546619 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page